These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25325295)

  • 1. A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors.
    Rigaux G; Roullin VG; Cadiou C; Portefaix C; Van Gulick L; Bœuf G; Andry MC; Hoeffel C; Vander Elst L; Laurent S; Muller R; Molinari M; Chuburu F
    Nanotechnology; 2014 Nov; 25(44):445103. PubMed ID: 25325295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of PLGA based nanoparticles for imaging guided applications.
    Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
    Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
    Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
    Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
    Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block copolymer-based gadolinium nanoparticles as MRI contrast agents with high T1 relaxivity.
    Hou S; Tong S; Zhou J; Bao G
    Nanomedicine (Lond); 2012 Feb; 7(2):211-8. PubMed ID: 22339134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
    Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
    J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-cured PMMA/PEI core/shell nanoparticles surface-modified with Gd-DTPA for T1 MR imaging.
    Ratanajanchai M; Lee DH; Sunintaboon P; Yang SG
    J Colloid Interface Sci; 2014 Feb; 415():70-6. PubMed ID: 24267331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nile Red Loaded PLGA Nanoparticles Surface Modified with Gd-DTPA for Potential Dual-Modal Imaging.
    Li Q; Li C; Tong W
    J Nanosci Nanotechnol; 2016 Jun; 16(6):5569-76. PubMed ID: 27427598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication and Characterization of Gd-DTPA-Loaded Chitosan-Poly(Acrylic Acid) Nanoparticles for Magnetic Resonance Imaging.
    Ahmed A; Zhang C; Guo J; Hu Y; Jiang X
    Macromol Biosci; 2015 Aug; 15(8):1105-14. PubMed ID: 25846258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
    Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
    ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability.
    Hatakeyama W; Sanchez TJ; Rowe MD; Serkova NJ; Liberatore MW; Boyes SG
    ACS Appl Mater Interfaces; 2011 May; 3(5):1502-10. PubMed ID: 21456529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
    Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J; Rathi M; Lalan M; Misra A
    Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
    Shao YZ; Liu LZ; Song SQ; Cao RH; Liu H; Cui CY; Li X; Bie MJ; Li L
    Contrast Media Mol Imaging; 2011; 6(2):110-8. PubMed ID: 21504064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.
    Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J
    Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.